MEI Pharma (MEIP) News Today → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free MEIP Stock Alerts $3.10 -0.16 (-4.91%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.comamericanbankingnews.com - April 21 at 2:14 AM5 Cheap Penny Stocks to Buy According to Analystsinsidermonkey.com - April 18 at 12:16 AMMEI Pharma shelves plans for a second return of capitalmsn.com - April 11 at 6:20 PMMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344businesswire.com - April 11 at 8:02 AMMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patientsbusinesswire.com - April 11 at 8:00 AMMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forumbusinesswire.com - April 10 at 8:00 AMMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemiafinance.yahoo.com - March 26 at 8:50 AM3 Pharma Stocks Outperforming the Competitionstocknews.com - March 20 at 2:03 PMMEI Pharma Inc (MEIP)investing.com - March 3 at 3:29 PMMEIP MEI Pharma, Inc.seekingalpha.com - February 29 at 11:44 PMGlancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)businesswire.com - February 15 at 3:02 PMGlancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)businesswire.com - February 15 at 1:06 PMMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlightsfinance.yahoo.com - February 13 at 9:33 PMMEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - February 13 at 9:33 PMMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlightsbusinesswire.com - February 13 at 5:05 PMMEI Pharma Inc.wsj.com - February 8 at 11:05 AMIs MEI Pharma (MEIP) Attractively Priced?finance.yahoo.com - February 8 at 11:05 AMAcceleron Pharmaforbes.com - January 18 at 8:00 AMMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024finance.yahoo.com - January 16 at 7:59 PMMEI Pharma Stock (NASDAQ:MEIP), Short Interest Reportbenzinga.com - December 27 at 8:54 PMMEI Pharma Stock (NASDAQ:MEIP) Dividends: History, Yield and Datesbenzinga.com - December 27 at 8:54 PMMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023finance.yahoo.com - December 11 at 3:14 PMStifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)markets.businessinsider.com - November 16 at 6:44 AMMEI Pharma Inc MEIPmorningstar.com - November 14 at 9:06 PMMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlightsfinance.yahoo.com - November 9 at 7:06 PMMEI Pharma to Present at the Stifel 2023 Healthcare Conferencefinance.yahoo.com - November 8 at 9:45 AMMEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stockfinance.yahoo.com - November 6 at 9:00 PMMEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023finance.yahoo.com - November 2 at 9:44 AMMEI Pharma Enters into Agreement with Anson Funds and Cable Car Capitalfinance.yahoo.com - November 1 at 1:49 PMMEI Pharma Recommends Stockholders Not to Consentfinance.yahoo.com - October 17 at 6:56 PMAstraZeneca's (AZN) Tagrisso Combo Gets FDA's Priority Reviewfinance.yahoo.com - October 17 at 1:55 PMEditas (EDIT) Gets FDA's RMAT Tag for Gene Therapy to Treat SCDfinance.yahoo.com - October 17 at 1:55 PMCatalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapsefinance.yahoo.com - October 16 at 3:12 PMMEI Pharma Adopts Limited-Duration Stockholder Rights Planfinance.yahoo.com - October 2 at 8:47 AMAll You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buyfinance.yahoo.com - September 29 at 3:49 PMMEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actionsstockhouse.com - September 28 at 5:43 PMMEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actionsfinance.yahoo.com - September 28 at 5:43 PMMEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - September 27 at 10:21 AMQ4 2023 MEI Pharma Inc Earnings Callfinance.yahoo.com - September 27 at 10:21 AMAnson And Cable Car Send Letter to MEI Pharma Stockholdersfinance.yahoo.com - September 26 at 6:13 PMMEI Pharma Reports Fiscal Year 2023 Results and Operational Highlightsfinance.yahoo.com - September 26 at 6:13 PMAnson Funds Management LP Acquires Shares in MEI Pharma Incfinance.yahoo.com - September 26 at 1:13 PMEarnings Outlook For MEI Pharmabenzinga.com - September 25 at 2:52 PMAnson Funds Management LP Acquires Additional Shares in MEI Pharma Incfinance.yahoo.com - September 23 at 9:45 AMMEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023finance.yahoo.com - September 21 at 10:16 AMSTOCKHOLDER ALERT: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.markets.businessinsider.com - September 18 at 3:44 PMCORRECTION: Abbott Cooper PLLC Announces Investigation Into Possible Violations of Fiduciary Duty by the Board of Mei Pharma, Inc.markets.businessinsider.com - September 18 at 3:44 PMMEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Carfinance.yahoo.com - September 18 at 10:44 AMMEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancerfinance.yahoo.com - August 16 at 12:30 PMCambridge biotech cuts most staffers after merger falls apartbizjournals.com - July 26 at 4:10 PM Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address AI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry MEIP Media Mentions By Week MEIP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEIP News Sentiment▼0.000.41▲Average Medical News Sentiment MEIP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEIP Articles This Week▼21▲MEIP Articles Average Week Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Synlogic News Onconova Therapeutics News Lumos Pharma News Cumberland Pharmaceuticals News Biora Therapeutics News Vincerx Pharma News NeuroSense Therapeutics News FSD Pharma News Bullfrog AI News BioVie News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MEIP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & CompanyKeep Your Eyes on This Power-Mad PoliticianAltimetry"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
